The TCR targeting an HLA-A*02:01 presented epitope of CEA, described earlier, was found to induce severe colitis in all three colorectal cancer patients tested (7, 193) because of baseline CEA expression in colonic mucosa. Here, CEACAM5 is linked to colorectal cancer.